Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Beliefs about Appropriate Antibacterial Therapy, California
  • Published Date:
    Jul 2005
  • Source:
    Emerg Infect Dis. 11(7):1138-1141.
Filetype[PDF-139.50 KB]


Details:
No Related Documents.
You May Also Like:
  1. Antimicrobial Resistance Determinants and Future Control
    Personal Author:
    Harbarth, Stephan; Samore, Matthew H.;
    Published Date:
    Jun 2005
    Source:
    Emerg Infect Dis. 11(6):794-801.
    Description:
    At the beginning of the 21st century, antimicrobial resistance is common, has developed against every class of antimicrobial drug, and appears to be spreading into new clinical niches. We describe determinants likely to influence the future epidemiol...
    File Type:
    Filetype[PDF - 280.35 KB]
  2. Diagnosis and management of tickborne rickettsial diseases : Rocky Mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis — United States : a practical guide for health care and public health professionals
    Personal Author:
    Biggs, Holly M.; Barton Behravesh, Casey; Bradley, Kristy K.; Dahlgren, F. Scott; Drexler, Naomi A.; Dumler, J. Stephen; Folk, Scott M.; Kato, Cecilia Y.Lash, R. Ryan; Levin, Michael L.; Massung, Robert F.; Nadelman, Robert B.; Nicholson, William L.; Paddock, Christopher D.; Pritt, Bobbi S.; Traeger, Marc S.;
    Corporate Authors:
    National Center for Emerging and Zoonotic Infectious Diseases (U.S.)
    Published Date:
    May 13, 2016
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 65, no. RR-2
    Description:
    Tickborne rickettsial diseases continue to cause severe illness and death in otherwise healthy adults and children, despite the availability of low-cost, effective antibacterial therapy. Recognition early in the clinical course is critical because th...
    Status:
    current
    File Type:
    Filetype[PDF - 5.49 MB]
  3. International Conference on Emerging Infectious Diseases 2000
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). National Center for Infectious Diseases (U.S.).
    Conference Authors:
    International Conference on Emerging Infectious Diseases (2000 : Atlanta, GA)
    Published Date:
    June 2001
    Series:
    Emerging infectious diseases ; v. 7, no. 3, suppl., p. 493-564
    Description:
    Papers presented at the 2nd International Conference on Emerging Infectious Diseases (ICEID) held July 16-19, 2000, in Atlanta, Georgia.
    File Type:
    Filetype[PDF - 2.24 MB]
  4. Human MRSA Isolates with Novel Genetic Homolog, Germany
    Personal Author:
    Kriegeskorte, André; Ballhausen, Britta; Idelevich, Evgeny A.; Köck, Robin; Friedrich, Alexander W.; Karch, Helge; Peters, Georg; Becker, Karsten;
    Published Date:
    Jun 2012
    Source:
    Emerg Infect Dis. 18(6):1016-1018.
    File Type:
    Filetype[PDF - 173.22 KB]
  5. Challenges and Opportunities of Nontraditional Approaches to Treating Bacterial Infections
    Personal Author:
    Tse, Brian N.; Adalja, Amesh A.; Houchens, Christopher; Larsen, Joseph; Inglesby, Thomas V.; Hatchett, Richard;
    Published Date:
    Aug 01 2017
    Source:
    Clin Infect Dis. 65(3):495-500
    Description:
    Due to increasing rates of antimicrobial-resistant infections and the current inadequacy of the antibiotic pipeline, there is increasing interest in nontraditional approaches to antibacterial therapies. We define "traditional" agents as small-molecul...
    File Type:
    Filetype[PDF - 315.98 KB]